Related references
Note: Only part of the references are listed.Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping
Katrina Rack et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
Rashmi Kanagal-Shamanna et al.
MODERN PATHOLOGY (2022)
Guiding the global evolution of cytogenetic testing for hematologic malignancies
Yassmine M. N. Akkari et al.
BLOOD (2022)
Hybrid sequencing resolves two germline ultra-complex chromosomal rearrangements consisting of 137 breakpoint junctions in a single carrier
Jesper Eisfeldt et al.
HUMAN GENETICS (2021)
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myelodysplasies (GFM)
Thomas Cluzeau et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers
Eric J. Duncavage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses
Nikhil Shri Sahajpal et al.
GENES (2021)
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias
Valentin Lestringant et al.
GENES CHROMOSOMES & CANCER (2021)
Optical genome mapping enables constitutional chromosomal aberration detection
Tuomo Mantere et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes
Sally B. Killick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Beyond morphology: to be or not to be an MDS
Mar Mallo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes
Rashmi Kanagal-Shamanna et al.
CANCER (2021)
Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
Thomas Cluzeau et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors
Mariangela Sabatella et al.
JOURNAL OF PATHOLOGY (2021)
Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia
Zhenya Tang et al.
LEUKEMIA RESEARCH (2021)
The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia
Jonathan Lukas Luehmann et al.
CANCERS (2021)
Genome Sequencing in Myeloid Cancers
Torsten Haferlach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management
Guillermo Garcia-Manero et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard et al.
NATURE MEDICINE (2020)
Optical mapping of the 22q11.2DS region reveals complex repeat structures and preferred locations for non-allelic homologous recombination (NAHR)
Steven Pastor et al.
SCIENTIFIC REPORTS (2020)
Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS
Anna Stengel et al.
BLOOD ADVANCES (2020)
Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
Guillermo Montalban-Bravo et al.
BLOOD ADVANCES (2020)
Long-Read Sequencing Emerging in Medical Genetics
Tuomo Mantere et al.
FRONTIERS IN GENETICS (2019)
Structural variant calling: the long and the short of it
Medhat Mahmoud et al.
GENOME BIOLOGY (2019)
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Eytan M. Stein et al.
BLOOD (2018)
Partial tandem duplication of KMT2A (MLL) may predict a subset of myelodysplastic syndrome with unique characteristics and poor outcome
Sarah M. Choi et al.
HAEMATOLOGICA (2018)
Partial tandem duplication of KMT2A (MLL) may predict a subset of myelodysplastic syndrome with unique characteristics and poor outcome
Sarah M. Choi et al.
HAEMATOLOGICA (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
Q-Y Sun et al.
LEUKEMIA (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory
Rashmi Kanagal-Shamanna et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Coming of age: ten years of next-generation sequencing technologies
Sara Goodwin et al.
NATURE REVIEWS GENETICS (2016)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q)
Rashmi Kanagal-Shamanna et al.
CANCER GENETICS (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53
Rashmi Kanagal-Shamanna et al.
CANCER (2012)
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Julie Schanz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Repetitive DNA and next-generation sequencing: computational challenges and solutions
Todd J. Treangen et al.
NATURE REVIEWS GENETICS (2012)
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
Ramon V. Tiu et al.
BLOOD (2011)
APPLICATIONS OF NEXT-GENERATION SEQUENCING Genome structural variation discovery and genotyping
Can Alkan et al.
NATURE REVIEWS GENETICS (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Alu repeats and human genomic diversity
MA Batzer et al.
NATURE REVIEWS GENETICS (2002)